Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Results of right ventricular outflow tract stenting as a primary palliation in symptomatic children having Fallot type of lesion.

Cardiology in the young·2026
Same author

Double-orifice mitral valve causing left ventricular outflow tract obstruction: a hitherto unreported entity.

Cardiology in the young·2025
Same author

Anomalous systemic venous drainage in truncus arteriosus - An unusual association.

Annals of pediatric cardiology·2025
Same author

Transcatheter Versus Surgical Correction of Superior Sinus Venosus Defects: Comparison of the Outcomes and Late Complications.

Pediatric cardiology·2025
Same author

Hybrid decision support system disaster management: application of lattice ordered q-rung linear Diophantine fuzzy hypersoft sets.

PeerJ. Computer science·2025
Same author

Author Correction: Extended PROMETHEE method with (p,q)-rung linear Diophantine fuzzy sets for robot selection problem.

Scientific reports·2025

Related Experiment Video

Updated: Jun 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

Hydrocortisone induced hypertrophic cardiomyopathy.

J Vimala, Atul Prabhu, Sreeja Pavithran

    International Journal of Cardiology
    |January 5, 2010
    PubMed
    Summary

    Steroid administration in a preterm infant caused recurrent hypertrophic obstructive cardiomyopathy (HOCM). The condition resolved upon drug cessation, indicating a direct link between steroids and HOCM development in neonates.

    More Related Videos

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
    10:21

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

    Published on: June 14, 2016

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
    06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Related Experiment Videos

    Last Updated: Jun 17, 2026

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
    03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
    10:21

    Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

    Published on: June 14, 2016

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
    06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Area of Science:

    • Neonatal Medicine
    • Pediatric Cardiology
    • Pharmacology

    Background:

    • Broncho-pulmonary dysplasia is a common complication in preterm infants.
    • Steroids are sometimes used to manage broncho-pulmonary dysplasia.
    • Hypertrophic obstructive cardiomyopathy (HOCM) is a cardiac condition characterized by thickening of the heart muscle.

    Observation:

    • A preterm infant receiving hydrocortisone for broncho-pulmonary dysplasia developed HOCM.
    • Echocardiography revealed left ventricular hypertrophy and outflow tract obstruction.
    • The cardiac abnormalities resolved after discontinuing hydrocortisone.

    Findings:

    • Recurrent HOCM developed in the infant following a second course of hydrocortisone.
    • This suggests a causal relationship between steroid administration and HOCM in this patient.
    • The findings highlight a potential adverse effect of steroids in preterm neonates.

    Implications:

    • Steroid therapy in preterm infants may pose a risk for developing HOCM.
    • Careful cardiac monitoring is warranted in neonates treated with steroids.
    • Further research is needed to understand the mechanisms and prevalence of steroid-induced HOCM.